HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phosphorylation of seryl-tRNA synthetase by ATM/ATR is essential for hypoxia-induced angiogenesis.

Abstract
Hypoxia-induced angiogenesis maintains tissue oxygen supply and protects against ischemia but also enhances tumor progression and malignancy. This is mediated through activation of transcription factors like hypoxia-inducible factor 1 (HIF-1) and c-Myc, yet the impact of hypoxia on negative regulators of angiogenesis is unknown. During vascular development, seryl-tRNA synthetase (SerRS) regulates angiogenesis through a novel mechanism by counteracting c-Myc and transcriptionally repressing vascular endothelial growth factor A (VEGFA) expression. Here, we reveal that the transcriptional repressor role of SerRS is inactivated under hypoxia through phosphorylation by ataxia telangiectasia mutated (ATM) and ataxia telangiectasia mutated and RAD3-related (ATR) at Ser101 and Ser241 to attenuate its DNA binding capacity. In zebrafish, SerRSS101D/S241D, a phosphorylation-mimicry mutant, cannot suppress VEGFA expression to support normal vascular development. Moreover, expression of SerRSS101A/S241A, a phosphorylation-deficient and constitutively active mutant, prevents hypoxia-induced binding of c-Myc and HIF-1 to the VEGFA promoter, and activation of VEGFA expression. Consistently, SerRSS101A/S241A strongly inhibits normal and tumor-derived angiogenesis in mice. Therefore, we reveal a key step regulating hypoxic angiogenesis and highlight the importance of nuclear SerRS in post-developmental angiogenesis regulation in addition to vascular development. The role of nuclear SerRS in inhibiting both c-Myc and HIF-1 may provide therapeutic opportunities to correct dysregulation of angiogenesis in pathological settings.
AuthorsYi Shi, Ze Liu, Qian Zhang, Ingrid Vallee, Zhongying Mo, Shuji Kishi, Xiang-Lei Yang
JournalPLoS biology (PLoS Biol) Vol. 18 Issue 12 Pg. e3000991 (12 2020) ISSN: 1545-7885 [Electronic] United States
PMID33351793 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiogenesis Inducing Agents
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Transcription Factors
  • Vascular Endothelial Growth Factor A
  • Zebrafish Proteins
  • ATM protein, human
  • ATR protein, human
  • ATR protein, zebrafish
  • Ataxia Telangiectasia Mutated Proteins
  • Serine-tRNA Ligase
Topics
  • Angiogenesis Inducing Agents
  • Animals
  • Animals, Genetically Modified
  • Ataxia Telangiectasia (genetics)
  • Ataxia Telangiectasia Mutated Proteins (genetics, metabolism, physiology)
  • Cell Line
  • Female
  • HEK293 Cells
  • Humans
  • Hypoxia (metabolism, physiopathology)
  • Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)
  • Mice
  • Mice, Nude
  • Neovascularization, Pathologic (genetics)
  • Phosphorylation
  • Serine-tRNA Ligase (metabolism, physiology)
  • Transcription Factors (metabolism)
  • Vascular Endothelial Growth Factor A (genetics, metabolism)
  • Xenograft Model Antitumor Assays (methods)
  • Zebrafish (metabolism)
  • Zebrafish Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: